Safety, tolerability, and efficacy of orally administered cannabinoids in MS

被引：4
|
作者：
Russo, EB
机构：
来源：
NEUROLOGY | 2003年 / 60卷 / 04期
关键词：
D O I：
10.1212/WNL.60.4.729-a
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：729 / 729
页数：1
相关论文
共 50 条
  • [1] Safety, tolerability, and efficacy of orally administered cannabinoids in MS
    Killestein, J
    Hoogervorst, ELJ
    Reif, M
    Kalkers, NF
    van Loenen, AC
    Staats, PGM
    Gorter, RW
    Uitdehaag, BMJ
    Polman, CH
    NEUROLOGY, 2002, 58 (09) : 1404 - 1407
  • [2] Efficacy, tolerability, and safety of cannabinoids in gastroenterology. A systematic review
    Volz, M. S.
    Siegmund, B.
    Haeuser, W.
    SCHMERZ, 2016, 30 (01): : 37 - 46
  • [3] Efficacy and safety of fluorescein angiography with orally administered sodium fluorescein
    Hara, T
    Inami, M
    Hara, T
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1998, 126 (04) : 560 - 564
  • [4] Immunomodulatory effects of orally administered cannabinoids in multiple sclerosis
    Killestein, J
    Hoogervorst, ELJ
    Reif, M
    Blauw, B
    Smits, M
    Uitdehaag, BMJ
    Nagelkerlen, L
    Polman, CH
    JOURNAL OF NEUROIMMUNOLOGY, 2003, 137 (1-2) : 140 - 143
  • [5] Ocrelizumab in pediatric patients with MS: Efficacy, tolerability, and safety
    Zeydan, Burcu
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2023, 43 : A1 - A1
  • [6] Safety, efficacy and tolerability of a three-dose regimen of orally administered aqueous sodium phosphate for colonic cleansing prior to colonoscopy
    Barclay, RL
    GASTROINTESTINAL ENDOSCOPY, 2004, 59 (05) : AB132 - AB132
  • [7] Efficacy, Safety, and Tolerability of Orally Administered Atogepant for the Prevention of Episodic Migraine: Results from a Phase 2b/3 Study
    Goadsby, Peter J.
    Dodick, David W.
    Trugman, Joel M.
    Finnegan, Michelle
    Lakkis, Hassan
    Lu, Kaifeng
    Szegedi, Armin
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [8] EFFICACY, SAFETY, AND TOLERABILITY OF ORALLY ADMINISTERED ATOGEPANT FOR THE PREVENTION OF EPISODIC MIGRAINE: RESULTS FROM A PHASE 2B/3 STUDY
    Goadsby, P. J.
    Dodick, D. W.
    Trugman, J. M.
    Finnegan, M.
    Lakkis, H.
    Lu, K.
    Szegedi, A.
    CEPHALALGIA, 2018, 38 : 144 - 145
  • [9] Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers
    Yingxin Li
    Yang Li
    Li Li
    Wei Xue
    Kong Xin
    Titi Wang
    Aixin Shi
    Clinical Drug Investigation, 2023, 43 (6) : 413 - 420
  • [10] Pharmacokinetics, Safety, and Tolerability of Single-Dose Orally Administered Venglustat in Healthy Chinese Volunteers
    Li, Yingxin
    Li, Yang
    Li, Li
    Xue, Wei
    Xin, Kong
    Wang, Titi
    Shi, Aixin
    CLINICAL DRUG INVESTIGATION, 2023, 43 (06) : 413 - 420
12345